Evidence map

TrialESC heart failure2023

Impact of diabetes duration on left ventricular mass regression with empagliflozin.

Michael Moroney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37038614